Corcept Therapeutics (NASDAQ: CORT) crashed about 50% on Dec. 31 after the FDA requested additional data to support the efficacy of relacorilant, its candidate treatment for Cushing’s syndrome.The setback cast doubt on CORT’s pipeline strength…
Category:
Investing
-
-
Logan Mohtashami, a senior HousingWire analyst, believes mortgage rate stability – not rate cuts – will be the key driver for the US housing market in 2026.While many focus on the Fed policy, Mohtashami told…
-
Analysts increasingly believe Microsoft could reach a $5 trillion market valuation in early 2026.The analysis is driven by accelerating artificial intelligence monetisation, dominance in enterprise cloud infrastructure, and expanding operating margins that are reshaping the…
-
India’s financial ecosystem in 2025 was shaped less by headline-grabbing launches and more by consolidation across payments, lending, and trade finance. Digital rails expanded further into daily economic activity, regulatory frameworks stabilised after a period…
-
Looking ahead to 2026, Bitcoin price forecasts present a sharp divide between institutional optimism and cautionary signals from historical chart patterns. While major banks and crypto-native firms continue to predict higher prices driven by structural…